Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C A BOUCHER

Showing results (251-260 of 254) with videos related to

Pageof 26
Sort By:
You have reached the last page of results.This site can display upto 254 results.
The Journal of Infectious Diseases|April 1, 1997
High-dose nevirapine in previously untreated human immunodeficiency virus type 1-infected persons does not result in sustained suppression of viral replicationM D de Jong, S Vella, A Carr, et al.
HIV Medicine|August 25, 2010
Prediction of response to antiretroviral therapy by human experts and by the EuResist data-driven expert system (the EVE study)M Zazzi, R Kaiser, A Sönnerborg, et al.
Nature|February 2, 2002
Genome sequence of the plant pathogen Ralstonia solanacearumM Salanoubat, S Genin, F Artiguenave, et al.
Antimicrobial Agents and Chemotherapy|July 18, 2000
Prevalence and characteristics of multinucleoside-resistant human immunodeficiency virus type 1 among European patients receiving combinations of nucleoside analoguesK Van Vaerenbergh, K Van Laethem, J Albert, et al.
Pageof 26

Showing results (251-260 of 254) with videos related to

Sort By:
Pageof 26
You have reached the last page of results.This site can display upto 254 results.
The Journal of Infectious Diseases|April 1, 1997
High-dose nevirapine in previously untreated human immunodeficiency virus type 1-infected persons does not result in sustained suppression of viral replicationM D de Jong, S Vella, A Carr, et al.
HIV Medicine|August 25, 2010
Prediction of response to antiretroviral therapy by human experts and by the EuResist data-driven expert system (the EVE study)M Zazzi, R Kaiser, A Sönnerborg, et al.
Nature|February 2, 2002
Genome sequence of the plant pathogen Ralstonia solanacearumM Salanoubat, S Genin, F Artiguenave, et al.
Antimicrobial Agents and Chemotherapy|July 18, 2000
Prevalence and characteristics of multinucleoside-resistant human immunodeficiency virus type 1 among European patients receiving combinations of nucleoside analoguesK Van Vaerenbergh, K Van Laethem, J Albert, et al.
Pageof 26